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Abstract 
Purpose: To examine the biocompatibility and osteoinductive potential of sub-microfibrous membranes 
with cells in vitro and in vivo.  
Methods: Polylactic acid (PLA) and poly-ε-caprolactone (PCL) were blended at various volume ratios 
(PLA:PCL = 100:0, 70:30, 50:50, 30:70 and 0:100) and each membrane form was prepared by 
electrospinning. Cell viability, biocompatibility, and bone regeneration were measured.  
Results: The membranes from the PLA/PCL blends prepared by an electrospinning process showed a 
range of diameter distribution ranging from 1,580 to 550 nm. The cells of 100 % PCL membrane 
(smallest diameter) exhibited significantly higher adhesion and proliferation than those of the other 
membranes. Among the membranes from PLA/PCL blends, PCL membrane showed weak inflammatory 
changes in the early stages of implantation without acute or chronic inflammation. PCL membranes with 
osteogenically-induced cells successfully stimulated new bone formation in a rate calvarial defect 
model.  
Conclusion: The results indicate that biodegradable PCL sub-microfibrous membrane produced by 
electrospinning process seems to have excellent biocompatibility, and may be used as a scaffold for 
bone tissue engineering. 
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Fibrous membranes of biodegradable polymers 
fabricated by an electrospinning technique have 
been developed for medical applications such as 
vascular graft [1], skin substitution [2], nerve 
regeneration [3], bone tissue engineering [4], and 
guided bone regeneration for dental surgery [5]. 
Many studies have been devoted to evaluating 
the suitability of these applications for in vitro and 
in vivo models [6]. Biodegradable substance, 
such as poly (lactic acid) (PLA), Poly-ε-
caprolactone (PCL), poly (glycolic acid) (PGA), 
and their copolymers, are regarded as the ideal 
materials for medical applications. 
 
To develop an ideal biomaterial, we need to take 
into account not only its biocompatibility but also 
the balance between the biodegradation rate of 
exogenous polymers and the repair rate of the 
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home tissue. Biodegradation rate is stimulated by 
penetration, attachment, growth, and 
differentiation of functional cells, but is inhibited 
by inflammatory responses and tissue rejection 
reactions. For optimal tissue engineering of 
damaged tissue, the biodegradation of the 
implanted scaffold, by host enzymatic and 
hydrolytic activities, must be followed by tissue 
replacement and functional restoration such as 
mechanical strength and original cellular 
activities. 
 
Some studies have focused on the 
biodegradability [7], physic-chemical properties 
[8] and in vitro biocompatibility [2] of aliphatic 
polyesters and aliphatic polyester blends. In this 
work, two synthetic polymers were selected; 
poly-ε-caprolactone (PCL) and poly-lactic acid 
(PLA). The polymers were blended at different 
ratios and were subjected to electrospinning. To 
examine biocompatibility of these membranes, 
human mesenchymal stem cells (hMSCs) were 
grown on the PCL/PLA composite membranes, 
and the tissue responses were examined in the 
subcutaneous tissues of mice. To assess the 
efficiency of bone formation, we evaluated the 
bone hilling activity stimulated by bone marrow-
derived stromal cells (BMCs) with or without 
osteogenic induction on the membranes in a rat 




Preparation and characterization of fibrous 
membrane 
 
PLA (Sigma–Aldrich USA) and PCL (Sigma–
Aldrich, USA) were separately dissolved in 2,2,2-
trifluoroethanol (TFE, Sigma–Aldrich). The 
volume ratio of PLA and PCL in the mixed 
solutions was either 100:0, 70:30, 50:50, 30:70 
or 0:100. The mixed solutions were stirred for 24 
h. Each solutions were applied into the 10ml 
syringe to electrospinning. An 15 kV voltage was 
applied and the tip to collector distance was 
maintained at 10 cm.  The fibrous membranes 
were dried under vacuum to evaporate the 
solvent. The morphology of the samples was 
examined by scanning electron microscopy 
(SEM), and the diameter of the fibers was 
calculated from the SEM images. 
 
In vitro viability test  
 
Human mesenchymal stem cells (hMSC) were 
purchased from Lonza (Walkerville, USA) and 
maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) containing 4.5 g/ml D-glucose, 
10 % FBS, and 10 U/ml penicillin-streptomycin. 
 
The proliferation of hMSCs on fibrous 
membranes was evaluated using a MTS assay 
(Promega, USA). Briefly, hMSCs were seeded at 
a density of 2 × 105 cells/cm2 on various types of 
fibrous membranes in a 12-well plate at 0 days. 
The cells were cultured in the growth medium. 
Every 24 h, an MTS solution was added to each 
well, incubated for 30 min, and measured using a 
microplate reader (Molecular Devices, USA) at 
450 nm. The proliferation of hMSCs was 
observed by confocal microscopy. The cells were 
processed, as described in the MTS assay. All 
membranes were fixed with chilled ethanol every 
24 h, and 50 μg/ml propidium iodide solution was 
added to each well. The membranes with the 
cells were incubated for 15 min and washed with 
PBS briefly. Each time the number of cells in the 
fibrous membranes was counted and 
photographed by LSM510 confocal microscopy 
(Carl Zeiss, Switzerland). 
 
In vivo biocompatibility test 
 
The animal protocol used in this study was 
reviewed and approved based on ethical 
procedures and scientific care by the Dankook 
University-Institutional Animal Care and Use 
Committee (DKU-IACUC). To implant the fibrous 
membranes, incisions were cut on the dorsal 
section of each mouse and the fibrous 
membranes were and implanted into the 
incisions. The incisions were then sutured. After 
two weeks, the mice were sacrificed, and the 
entire graft was harvested with surrounding 
tissue. The samples were fixed with 4 % 
paraformaldehyde and were subjected to 
Hematoxylin-Eosin staining.  
 
Assessment of bone regeneration in calvarial 
defects 
 
To evaluate whether bone marrow-derived 
stromal cells (BMCs) with osteoinduction 
participate in in vivo bone formation, a calvarial 
bone defect model was used for this assay in 8-
week-old Sprague-Dawley (SD) rats. BMCs were 
induced in osteogenic media for 7 days after 
growth in DMEM for 7 days. The osteogenic 
media consisted of 50 mM L-ascorbic 2-
phosphate, 10 mM glycerol-2-phosphate 
disodium, and 1 μM dexamethasone, and the 
medium was replaced every 3 days. 
 
Under general anesthesia, induced by an 
intramuscular injection of ketamine/rumpun (80 
and 10 mg/kg), the external cortical plates were 
removed using a 5-mm trephine bur with saline 
irrigation [9] [10]. One asymmetrical defect was 
made on the right side of the midline of each rat. 
Extreme care was taken not to harm the brain 
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membranes. The bone defects were washed with 
normal saline, and membranes were then 
applied to the defects.  
 
Animals were divided into three groups: Group 1, 
PCL membrane only (n=3); Group 2, PCL 
membrane with non-induced rBMCs (n=3); 
Group 3, PCL membrane with osteogenic 
induction of rBMCs (n=3); No 
immunosuppressants were used. After 4 weeks, 
the rats were euthanized, and the transplanted 
constructs were dissected carefully and taken out 
of the surrounding soft tissue. 
 
Microradiographs of the skull were performed 
using an Image Station FX (Kodak, Rochester, 
NY) for 6 s at 12.5 kVp. After the radiographs 
had been taken, the defected calvaria samples 
were de-calcified with 20 % EDTA. The samples 
were then dehydrated in a graded series of 
ethanol and embedded in paraffin. The center of 
the defect area was sectioned to a 4 μm 
thickness, stained with Masson’s Trichrome, and 
photographed using an optical microscope 




All results are presented as mean and stabdard 
deviation (SD) and were evaluated using one-
way analysis of variation (ANOVA) and also 
Tukey’s analysis for pair wise comparison. 





Structural morphology of the fibrous 
membrane 
 
As shown in Figure 1, fibrous membranes 
produced from different volume ratios of PLA and 
PCL by an electrospinning technique led to a 
range of diameter distributions. The three-
dimensional fibrous structures with polygonal, 
interconnected pores and randomly oriented 
fibers were evaluated for their diameter range. 
The diameters of homogenous PLA fabrications 
was determined to be 1,580 ± 232 nm (Figure 1A 
and F), PLA: PCL=3:7 835 ± 123 nm (Fig. 1B 
and G), PLA: PCL = 5:5 842±97 nm (Fig. 1C and 
H), PLA: PCL = 3:7 743 ± 173 nm (Figure 1D 
and I), and the homogenous PCL 558 ± 142 nm 
(Figure 1E and J). 
 
Viability of hMSC on the fibrous membrane  
 
The viability of the hMSCs on the fibrous 
membrane was examined using an MTS assay 
and PI staining (Fig. 2). On day 0, the hMSCs 
were seeded onto the various types of 
membrane, and their attachment and 
proliferation were observed after 7 days. As 
shown in Fig. 2a, the hMSCs were showed 
exponential growth patterns, without any 
cytotoxicity, for all types of membranes until day 
4. Cells on PCL fibrous membranes showed a 
significantly higher viability than those on any of 
the other materials, and were in a relatively 
quiescent state throughout the 7 day period after 
seeding, compared to those of other membranes. 
 
In vivo biocompatibility  
 
Histological analysis by optical pathological 
microscopy was performed to make a 
comparison of the infiltration to various types of 
membrane. The pore size of the fibrous 
membranes is too small for cells to penetrate in 
vitro. However in vivo cellular infiltration was 
observed in the subcutaneous tissue of mice 
examined in week 2. As shown in Figure 3, 
histological examination of subcutaneous 
implantation with fibrous membranes revealed an 
infiltration of histiocytes and lymphocytes in the 
area of the margin and center, respectively. 
There was no evidence of acute or chronic 
inflammation in any groups. Our results showed 
that hypertrophy of lining histiocytes and 
infiltration of lymphocytes in the membranes 
gradually decreased with increasing ratio of PCL. 
However, the difference was not determined to 
be statistically significant (p > 0.5). For this 
reason, PCL seems to be a suitable candidate as 
a degradable fibrous membrane for use in 
biomaterials. 
 
Bone healing in rat calvarial defect model 
 
Bone regeneration effects were evaluated in the 
rat calvarial defect model by Soft x-ray and 
histological staining after four weeks. From the 
Soft x-ray observation (Figure 4B, implantation of 
fibrous membranes with non-induced rBMSC 
(group 2) to calvarial defected rats showed 
limited bone formation at the periphery, as did 
membrane only group (group 1). In contrast, 
implantation of the membrane with osteogenic 
induction of rBMSC (group 3) showed a 
significantly greater extent of bone healing, both 
on the inside and peripheral regions of the 
defect, compared to other groups. The 
quantitative analysis of bone density was 
consistent with Soft X-ray images. The relative 
bone regeneration area of group 3 was 0.73 ± 
0.08 mm, which was significantly greater than 
that of group 2 (0.36 ± 0.07 mm) and group 1 
(0.28 ± 0.03 mm). 
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Figure 1: Ultrastructural morphology and fiber diameter distributions of PLA/PCL composites fabricated by the 
electrospinning technique. Microphotographs were made by SEM. (A) PLA 100 %, (B) PLA:PCL = 70:30, (C) 
PLA:PCL=50:50, (D) PLA:PCL=70:30, (E) PCL 100 % 
 
 
Figure 2: Cell proliferation on various PLA/PCL blended membranes. The proliferation of hMSC on the 
nanofibrous membrane was evaluated by an MTS assay and confirmed by PI staining. The hMSCs were seeded 
at a density of 2 × 105 cells/cm2 on various types of nanofibrous membranes put in a 12-well plate. The cells were 
cultured in growth medium. MTS assay and PI staining were performed every 24 h for 4 days. Each time, the 
viable cells on the nanofibrous membranes were assessed by a microplate reader and photographed by confocal 
microscopy. The data is expressed as the mean ± SD and the significance was determined at *p < 0.1, **p < 0.05 
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Figure 3: Histological analysis of the tissue adjacent to the nanofibrous membrane implanted subcutaneously in 
mice. The mice were sacrificed 2 weeks after various types of nanofibrous membranes were implanted. Multiple 
mononuclear elements, chiefly macrophages, and rare lymphocytes adhere to the membrane. Mild acute 
responses were observed in the PCL membrane. Some membranes exhibited fibrosis in the adjacent tissue. The 
slit under the membrane was probably due to artificial retraction of the tissue 
 
 
Figure 4: Photographs and soft X-rays of calvarial defects Bone marrow-derived stromal cells were isolated and 
maintained for passage three, and then plated onto 1cm × 1cm of a square nanofibrous membrane at a density 
of 2×104 cells/sheet. The cells were cultured with/without differentiation induction medium for 7 days. One 
asymmetrical defect was made on the right side of the midline in each rat. The PCL membrane with the cells was 
placed over the defects, and after 4 weeks, the rats were euthanized, and the transplanted constructs were 
dissected carefully and free from the surrounding soft tissue. Photographs (A) and microradiographs (B) of the 
skull were taken using Image station FX 
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Figure 5: Histological analysis of rBMSCs-engrafted membranes for the bone regeneration of calvarial defects. 
Representative tissue sections of the defect sites covered with the membrane without rBMSCs(A and D), the 
membrane with undifferentiated rBMSCs (B and E), and the membrane with differentiated rBMSCs (C and F) 
were stained by Mason-Trichome after 4 weeks. (A), (B) and (C) were with ×12.5, (D), (E) and (F) were with ×100 
magnification. The initial lesion site of calvaria (fill triangle) and islands of bone formation (black arrow), and 
osteocyte in the canal (empty triangle) were marked. 
 
Histological images of the implanted membranes 
4 weeks after surgery are shown in Figure 5. 
Masson’s Trichrome (MT) stained sections were 
analyzed with light microscopy at various levels 
of magnification, yielding information on the 
quality and histologic characteristics of bone 
regeneration. MT-stained Histological sections 
confirmed a significant amount of bone healing, 
consistent with the island of new bone in group 3 
(Figure 5 A), and also revealed a large number of 
collagen tissues near the island formation of new 
bone tissue. All of the newly formed bones 
tissues had osteocytes in the canal cavity (Figure 
5 C, D, E). 
 
In quantitative analysis (Figure 5B), the average 
of bony bridging ratios in the calvarial defects 
was 12.3 % for PCL membranes only (Group 1), 
22.2 % for PCL membranes with non-induced 
rBMSC (Group 2), and 73.1 % for PCL 
membranes with osteogenic induction of rBMSC 
(Group 3; Figure 5A, B). The bone bridging ratios 




The fiber diameter, biocompatibility, and 
degradation rate of the blended polymers are 
essential for guided bone regeneration in dental 
surgery. This provides vital information regarding 
protection from soft tissue penetration during the 
hard tissue regeneration. Several observations 
have shown that pure PLA is hard and brittle and 
that adding PCL can change its original 
properties to make it softer and more flexible. 
The elongation properties of PLA increase with 
the addition of PCL, but the strength decreased 
as the elongation properties increased [8]. PLA 
can degrade more quickly than PCL, and so, it 
needs a shorter time to fully regenerate tissues 
of damaged organs. In other words, the addition 
of PCL to membranes hastens regeneration.  
 
The fiber diameter of the blended polymers was 
estimated by SEM images. As shown in Fig. 1, 
fiber diameters of the blended polymers ranged 
from 500 nm to 1.5 μm. The relative fiber 
diameters of the blended polymers were ranked 
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as following: PLA > PLA/PCL (7/3) > PLA/PCL 
(5/5) > PLA/PCL (3/7) > PCL. Many studies have 
reported that fibrous membranes blended with 
different biodegradable polymers by an 
electrospinning technique resulted in a range of 
diameter distributions from 10 nm to a few 
micrometer [11,12].  
 
Biocompatibility was addressed regarding in vitro 
viability and in vivo tissue response. From our 
results, viable cells were more abundant on the 
PCL fibrous membrane than other PLA/PCL 
blended membranes, and the dominant diameter 
of the PCL fibrous membranes are the smallest 
among the PLA/PCL blended membranes. The 
fiber diameter of the fibrous membranes affects 
cell proliferation, migration, and penetration in 
the membranes. The rat hippocampal astrocyte 
(HA) and rat cerebro-microvascular endothelial 
cells (CEC) could penetrate to PCL microfibrous 
membranes, but not to PCL sub-microfibrous 
membranes [13]. For the viability of HUVECs, 
PCL membranes with a fiber diameter of 1.16 ± 
0.17 μm were more suitable than ones with fiber 
dimensions of 7.02 ± 1.03 μm [14].  
 
Several works demonstrated that electrospun 
fibrous membranes showed a minimized foreign 
body reaction in animal models in vivo, such as 
rat [15], rabbit [16] and sheep [17]. From our 
results, all membranes made of the blended 
polymers showed mild foreign body reaction, and 
the membrane with PCL had a lower 
inflammation than others, due to the less acidic 
products of degradation.  
 
Recently, several studies focused on stem cell 
transplantation with several osteogenic factors, 
such as BMP-2 [18], fibroblast growth factor 2 
[19], and the demineralized bone matrix [20], for 
bone regeneration in calvarial defect animal 
models. Moreover, multipotent adult stem cells 
seeded into the polyglycolic acid mesh can 
stimulate bone regeneration after 12 weeks, and 
without any osteogenic factors, in a rat calvarial 
defect model [21].  
 
In the bone repairing animal model, 
transplantation with differentiated stem cells 
showed a better result than that with the control 
or undifferentiated stem cells [22,23]. These 
results are in agreement with our observation 
that the PCL fibrous membrane with osteogenic 
induction of rBMCs in the calvarial defect model 
stimulated a more compact bone regeneration 
than the one with non-induced rBMCs after 4 
weeks. Furthermore, bone healing was observed 
in MT staining, which revealed areas of cortical 




The findings of the present study demonstrate 
that 100 % PCL fibrous membrane shows better 
biocompatibility and viability than PLA blended 
forms, and that bone regeneration ability is 
improved on PCL sub-microfibrous membranes 
with osteogenic-induced cells, compared to that 
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